Retagliptin

Anarana simika:

(R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine- 1-carboxylate phosphate

Kaody SMILES:

COC(C1=NC([N]2=C1CN(C(C[C@@H])(CC3=C(F)C=C(F)C(F)=C3)N)=O)CC2)C (F)(F)F)=O

InChi Code:

InChI=1S/C19H19F6N4O3/c1-32-17(31)16-14-8-28(2-3-29(14)18(27-16)19(23,24)25)15(3 0)6-10(26)4-9-5-12(21)13(22)7-11(9)20/h5,7,10,18H,2-4,6,8,26H2,1H3/ t10-,18?/m1/s1

InChi Key:

FXBCTRLEFVUDDC-DMPGVRBJSA-N

Keyword:

Retagliptin, SP-2086, SP2086,1174122-54-3, 1256756-88-3

Solubility:Mety levona amin'ny DMSO

fitahirizana:0 - 4°C mandritra ny fotoana fohy (andro na herinandro), na -20°C mandritra ny fotoana maharitra (volana).

Famaritana:

Retagliptin, fantatra ihany koa amin'ny hoe SP-2086, dia inhibitor DPP-4 azo ampiasaina amin'ny fitsaboana ny diabeta karazana 2.

Tanjona: DPP-4